Arcturus Therapeutics Holdings, Inc. (ARCT)
15.53
-0.29
(-1.83%)
USD |
NASDAQ |
Sep 08, 11:52
Arcturus Therapeutics Holdings Cash and Short Term Investments (Quarterly) : 191.48M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 191.48M |
| March 31, 2026 | 211.38M |
| December 31, 2025 | 230.91M |
| September 30, 2025 | 235.36M |
| June 30, 2025 | 251.47M |
| March 31, 2025 | 255.45M |
| December 31, 2024 | 292.03M |
| September 30, 2024 | 292.18M |
| June 30, 2024 | 315.33M |
| March 31, 2024 | 343.40M |
| December 31, 2023 | 347.00M |
| September 30, 2023 | 346.92M |
| June 30, 2023 | 378.47M |
| March 31, 2023 | 327.94M |
| December 31, 2022 | 391.88M |
| September 30, 2022 | 237.68M |
| June 30, 2022 | 283.49M |
| March 31, 2022 | 319.68M |
| December 31, 2021 | 370.49M |
| September 30, 2021 | 413.88M |
| June 30, 2021 | 433.57M |
| March 31, 2021 | 466.84M |
| December 31, 2020 | 462.90M |
| September 30, 2020 | 307.02M |
| June 30, 2020 | 136.11M |
| Date | Value |
|---|---|
| March 31, 2020 | 59.47M |
| December 31, 2019 | 71.35M |
| September 30, 2019 | 74.17M |
| June 30, 2019 | 55.84M |
| March 31, 2019 | 31.22M |
| December 31, 2018 | 36.71M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 48.74M |
| September 30, 2017 | 39.82M |
| June 30, 2017 | 41.19M |
| March 31, 2017 | 45.25M |
| December 31, 2016 | 50.24M |
| September 30, 2016 | 51.35M |
| June 30, 2016 | 53.08M |
| March 31, 2016 | 53.23M |
| December 31, 2015 | 50.84M |
| September 30, 2015 | 35.51M |
| June 30, 2015 | 41.09M |
| March 31, 2015 | |
| December 31, 2014 | 21.70M |
| September 30, 2014 | 29.44M |
| June 30, 2014 | 38.94M |
| March 31, 2014 | 44.42M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Exelixis, Inc. | 839.38M |
| PTC Therapeutics, Inc. | 2.229B |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |